September 27, 2016 10:40 AM ET


Company Overview of Aderis Pharmaceuticals, Inc.

Company Overview

As of July 15, 2005, Aderis Pharmaceuticals, Inc. was acquired by Schwarz Pharma Ltd. Aderis Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development, manufacture, and commercialization of pharmaceuticals for the therapeutic treatment of central nervous system, cardiovascular, and inflammatory diseases. It focuses on developing indications for Parkinson’s disease, restless leg syndrome, cardiac image stress testing, atrial fibrillation, and wound healing. Aderis Pharmaceuticals, Inc. has strategic alliances with Schwarz Pharma AG and King Pharmaceuticals. It was formerly known as Discovery Therapeutics, Inc. and changed its name to Aderis Pharmaceuticals, ...

85 Main Street

Hopkinton, MA 01748

United States

Founded in 1994

21 Employees





Key Executives for Aderis Pharmaceuticals, Inc.

Aderis Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aderis Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at